查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598481

毒理學藥物篩檢市場：按產品、測試和應用 - 全球預測 2025-2030

Toxicology Drug Screening Market by Product (Animal Models, Instruments, Reagents & Consumables), Testing (In Silico, In Vitro, In Vivo), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年毒理學藥物篩檢市值為270.7億美元，預計2024年將達到305.9億美元，複合年成長率為13.38%，到2030年將達到652.2億美元。

毒理學藥物篩檢市場被定義為專注於檢測生物樣本中藥物及其代謝物的存在和濃度的醫學診斷領域。由於藥物濫用的增加、職場、體育和法律環境中常規藥物檢測的需要以及對新藥的需求不斷成長，該市場至關重要。應用範圍包括醫療保健、體育、刑事司法和職場安全，最終用途包括醫院、實驗室、執法和家庭測試。主要成長動力包括藥物濫用的增加、強制藥物篩檢的更嚴格法規、檢測套組的技術進步以及對職場藥物檢測的日益關注。開拓新市場的機會在於拓展認知度和滲透率仍較低的新興市場，以及開發快速、非侵入性的檢測方法。此外，利用人工智慧和機器學習進行毒理學測試資料分析具有巨大潛力。

主要市場統計
基準年[2023] 270.7億美元
預測年份 [2024] 305.9億美元
預測年份 [2030] 652.2億美元
複合年成長率（%） 13.38%

相反，市場面臨測試設備高成本、影響測試準確性的誤報、隱私問題和監管複雜性等限制。此外，一些地區圍繞藥物測試的恥辱可能會阻礙市場成長。創新可以集中在開發更實惠、更準確的檢測套組、小型化照護端設備以及加快測試過程。特別是，對唾液和呼吸分析等非侵入性測試方法的研究是一個有前途的途徑。市場競爭非常激烈，現有企業專注於技術進步和策略聯盟，而新參與企業可能會開拓個人化醫療或特定藥物類別等利基市場。為了方便而進行遠端和家庭測試的持續趨勢進一步凸顯了該市場不斷發展的性質。因此，尋求成長的公司應該投資於研發、策略夥伴關係關係以及適合當地需求的市場擴大策略。

市場動態：快速發展的毒理學藥物篩檢市場的關鍵市場洞察

毒理學藥物篩檢市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 職場藥物檢測的增加和床邊檢測 (POCT) 設備的高普及率
    • 增加高階藥物篩檢設備、試劑和套件的可用性
    • 增加政府毒理學測試支出
  • 市場限制因素
    • 毒理藥物篩檢試驗高成本
  • 市場機會
    • 先進毒理學藥物篩檢試驗簡介
    • 食品、飲料和化學工業擴大採用毒理學藥物篩檢
  • 市場挑戰
    • 與毒理學藥物篩檢相關的更長的樣本測試時間

波特五力：駕馭毒理學藥物篩檢市場的策略工具

波特的五力架構是了解毒理學藥物篩檢市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解毒理學藥物篩檢市場的外部影響

外部宏觀環境因素在塑造毒理學藥物篩檢市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解毒理學藥物篩檢市場的競爭格局

毒理學藥物篩檢市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣毒理學藥物篩檢市場供應商的績效評估

FPNV定位矩陣是評估毒理學藥物篩檢市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了毒理學藥物篩檢市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，毒理學藥物篩檢市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加職場藥物檢測的實施和就地檢驗(POCT) 設備的廣泛採用
      • 提高高性能藥物篩檢儀器、試劑和套件的可用性
      • 增加政府在毒性測試方面的支出
    • 抑制因素
      • 毒理藥物篩檢試驗高成本
    • 機會
      • 先進毒理學藥物篩檢試驗簡介
      • 食品飲料和化學工業擴大採用毒理學藥物篩檢
    • 任務
      • 與毒理學藥物篩檢相關的樣本測試週轉時間增加
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章毒理學藥物篩檢市場：依產品

  • 動物模型
  • 裝置
  • 試劑/耗材
  • 軟體

第7章 毒理學藥物篩檢試驗市場

  • 模擬
  • 體外
  • In vivo

第8章毒理學藥物篩檢市場：依應用分類

  • 發育和生殖毒性
  • 內分泌干擾
  • 免疫毒性
  • 全身毒性

第9章美洲毒理學藥物篩檢市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太毒理學藥物篩檢市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲毒理學藥物篩檢市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc.
  • Charles River Laboratories International, Inc.
  • Clinical Reference Laboratory, Inc.
  • Enzo Life Sciences, Inc.
  • Eurofins Scientific SE
  • GE Healthcare
  • Laboratory Corporation of America Holdings
  • Promega Corporation
  • Quest Diagnostics
  • Selvita SA
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • Wuxi AppTec Co., Ltd.
Product Code: MRR-AD517FAA7D9A

The Toxicology Drug Screening Market was valued at USD 27.07 billion in 2023, expected to reach USD 30.59 billion in 2024, and is projected to grow at a CAGR of 13.38%, to USD 65.22 billion by 2030.

The toxicology drug screening market is defined as the segment of medical diagnostics focused on detecting the presence and concentration of drugs and their metabolites in biological samples. This market is crucial due to rising substance abuse, the need for routine drug testing in workplaces, sports, legal environments, and the growing demand for new drugs. The applications extend to healthcare, sports, criminal justice, and workplace safety, while the end-use scope largely includes hospitals, laboratories, law enforcement agencies, and in-home testing. Key growth drivers include the increasing prevalence of drug abuse, stringent regulations mandating drug screening, technological advancements in testing kits, and a growing emphasis on workplace drug testing. Emerging opportunities lie in expanding into emerging markets where awareness and adoption are still nascent and developing rapid, non-invasive testing methods. Additionally, leveraging AI and machine learning for data analysis in toxicology screens offers significant potential.

KEY MARKET STATISTICS
Base Year [2023] USD 27.07 billion
Estimated Year [2024] USD 30.59 billion
Forecast Year [2030] USD 65.22 billion
CAGR (%) 13.38%

Conversely, the market faces limitations such as the high cost of testing equipment, false positives affecting test accuracy, privacy concerns, and regulatory complexities. Moreover, the stigma associated with drug testing in certain regions can hinder market growth. Innovations could focus on developing more affordable and accurate testing kits, miniaturized point-of-care devices, and improving the speed of testing processes. Particularly, research into non-invasive testing methods like saliva or breath analysis offers promising avenues. The market is competitive, with established players focusing on technological advancements and strategic partnerships, while new entrants might explore niche areas such as personalized medicine or specific drug categories. The continued trend toward remote and home testing due to its convenience further underlines the nature of this evolving market. Therefore, companies aiming for growth should invest in research and development, strategic partnerships, and market expansion strategies tailored to localized needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Toxicology Drug Screening Market

The Toxicology Drug Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing practice of workplace drug testing and high penetration of point of care testing (POCT) devices
    • Growing availability of high-end drug screening instruments, reagent and kits
    • Rising government expenditure on toxicity testing
  • Market Restraints
    • High Cost of toxicology drug screening tests
  • Market Opportunities
    • Introduction of advanced toxicology drug screening tests
    • Rise in adoption of toxicology drug screening in the food and beverage industry, and chemical industry
  • Market Challenges
    • Longer time for sample testing associated with toxicology drug screening

Porter's Five Forces: A Strategic Tool for Navigating the Toxicology Drug Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Toxicology Drug Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Toxicology Drug Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Toxicology Drug Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Toxicology Drug Screening Market

A detailed market share analysis in the Toxicology Drug Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Toxicology Drug Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Toxicology Drug Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Toxicology Drug Screening Market

A strategic analysis of the Toxicology Drug Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Toxicology Drug Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International, Inc., Clinical Reference Laboratory, Inc., Enzo Life Sciences, Inc., Eurofins Scientific SE, GE Healthcare, Laboratory Corporation of America Holdings, Promega Corporation, Quest Diagnostics, Selvita S.A., Thermo Fisher Scientific Inc., Waters Corporation, and Wuxi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Toxicology Drug Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Animal Models, Instruments, Reagents & Consumables, and Software.
  • Based on Testing, market is studied across In Silico, In Vitro, and In Vivo.
  • Based on Application, market is studied across Developmental & Reproductive Toxicity, Endocrine Disruption, Immunotoxicity, and Systemictoxicity.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing practice of workplace drug testing and high penetration of point of care testing (POCT) devices
      • 5.1.1.2. Growing availability of high-end drug screening instruments, reagent and kits
      • 5.1.1.3. Rising government expenditure on toxicity testing
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of toxicology drug screening tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of advanced toxicology drug screening tests
      • 5.1.3.2. Rise in adoption of toxicology drug screening in the food and beverage industry, and chemical industry
    • 5.1.4. Challenges
      • 5.1.4.1. Longer time for sample testing associated with toxicology drug screening
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Toxicology Drug Screening Market, by Product

  • 6.1. Introduction
  • 6.2. Animal Models
  • 6.3. Instruments
  • 6.4. Reagents & Consumables
  • 6.5. Software

7. Toxicology Drug Screening Market, by Testing

  • 7.1. Introduction
  • 7.2. In Silico
  • 7.3. In Vitro
  • 7.4. In Vivo

8. Toxicology Drug Screening Market, by Application

  • 8.1. Introduction
  • 8.2. Developmental & Reproductive Toxicity
  • 8.3. Endocrine Disruption
  • 8.4. Immunotoxicity
  • 8.5. Systemictoxicity

9. Americas Toxicology Drug Screening Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Toxicology Drug Screening Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Toxicology Drug Screening Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Bio-Rad Laboratories Inc.
  • 4. Charles River Laboratories International, Inc.
  • 5. Clinical Reference Laboratory, Inc.
  • 6. Enzo Life Sciences, Inc.
  • 7. Eurofins Scientific SE
  • 8. GE Healthcare
  • 9. Laboratory Corporation of America Holdings
  • 10. Promega Corporation
  • 11. Quest Diagnostics
  • 12. Selvita S.A.
  • 13. Thermo Fisher Scientific Inc.
  • 14. Waters Corporation
  • 15. Wuxi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. TOXICOLOGY DRUG SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. TOXICOLOGY DRUG SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TOXICOLOGY DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TOXICOLOGY DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TOXICOLOGY DRUG SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TOXICOLOGY DRUG SCREENING MARKET DYNAMICS
  • TABLE 7. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ANIMAL MODELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN SILICO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN VITRO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IN VIVO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DEVELOPMENTAL & REPRODUCTIVE TOXICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ENDOCRINE DISRUPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IMMUNOTOXICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SYSTEMICTOXICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. TOXICOLOGY DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. TOXICOLOGY DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2023